163 related articles for article (PubMed ID: 8208268)
21. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
22. bcl-6 in lymphoma--sorting out a wastebasket?
Kluin PM
N Engl J Med; 1994 Jul; 331(2):116-8. PubMed ID: 8208254
[No Abstract] [Full Text] [Related]
23. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.
Kramer MH; Hermans J; Wijburg E; Philippo K; Geelen E; van Krieken JH; de Jong D; Maartense E; Schuuring E; Kluin PM
Blood; 1998 Nov; 92(9):3152-62. PubMed ID: 9787151
[TBL] [Abstract][Full Text] [Related]
25. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
Kawasaki C; Ohshim K; Suzumiya J; Kanda M; Tsuchiya T; Tamura K; Kikuchi M
Leuk Lymphoma; 2001; 42(5):1099-106. PubMed ID: 11697627
[TBL] [Abstract][Full Text] [Related]
26. High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin.
Liang R; Chan WP; Kwong YL; Xu WS; Srivastava G; Ho FC
Cancer Genet Cytogenet; 1997 Sep; 97(2):114-8. PubMed ID: 9283593
[TBL] [Abstract][Full Text] [Related]
27. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma.
Lo Coco F; Ye BH; Lista F; Corradini P; Offit K; Knowles DM; Chaganti RS; Dalla-Favera R
Blood; 1994 Apr; 83(7):1757-9. PubMed ID: 8142643
[TBL] [Abstract][Full Text] [Related]
28. Bcl-6 gene hypermutations in diffuse large B-cell lymphoma of primary gastric origin.
Liang R; Chan WP; Kwong YL; Chan AC; Xu WS; Au WY; Srivastava G; Ho FC
Br J Haematol; 1997 Dec; 99(3):668-70. PubMed ID: 9401082
[TBL] [Abstract][Full Text] [Related]
29. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S
Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases.
Tang SC; Visser L; Hepperle B; Hanson J; Poppema S
J Clin Oncol; 1994 Jan; 12(1):149-54. PubMed ID: 8270971
[TBL] [Abstract][Full Text] [Related]
32. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
Gebauer N; Bernard V; Feller AC; Merz H
Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
[TBL] [Abstract][Full Text] [Related]
33. Low incidence of BCL-6 gene alterations for diffuse large B-cell lymphomas in Taiwan Chinese.
Chen PM; Yang MH; Yu IT; Lin JT; Lin YC; Fan FS; Wang WS; Yen CC; Chiou TJ; Liu JH
Cancer; 2002 May; 94(10):2635-44. PubMed ID: 12173331
[TBL] [Abstract][Full Text] [Related]
34. BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
Butler M; Corbally N; Dervan PA; Carney DN
Br J Cancer; 1997; 75(11):1641-5. PubMed ID: 9184180
[TBL] [Abstract][Full Text] [Related]
35. Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma.
Barrans SL; O'Connor SJ; Evans PA; Davies FE; Owen RG; Haynes AP; Morgan GJ; Jack AS
Br J Haematol; 2002 May; 117(2):322-32. PubMed ID: 11972514
[TBL] [Abstract][Full Text] [Related]
36. Identification of genetic lesions associated with diffuse large-cell lymphoma.
Dalla-Favera R; Ye BH; Lo Coco F; Gaidano G; Lista F; Knowles DM; Louie DC; Offit K; Chaganti RS
Ann Oncol; 1994; 5 Suppl 1():55-60. PubMed ID: 8172819
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic features, prognosis and etiology of primary non-Hodgkin lymphoma of bone].
Zhou ZY; Shi QL; Zhou XJ; Lan JY; Wang JD; Huang WB; Chen JY; Ma HH; Zhou HB
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):90-3. PubMed ID: 17493381
[TBL] [Abstract][Full Text] [Related]
38. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma.
Houldsworth J; Mathew S; Rao PH; Dyomina K; Louie DC; Parsa N; Offit K; Chaganti RS
Blood; 1996 Jan; 87(1):25-9. PubMed ID: 8547649
[TBL] [Abstract][Full Text] [Related]
39. Bcl-6 protein expression in normal and neoplastic lymphoid tissues.
Falini B; Fizzotti M; Pileri S; Liso A; Pasqualucci L; Flenghi L
Ann Oncol; 1997; 8 Suppl 2():101-4. PubMed ID: 9209651
[TBL] [Abstract][Full Text] [Related]
40. A recurrent nonrandom translocation (3;7)(q27;p12) associated with BCL-6 gene rearrangement in B-cell diffuse large cell lymphoma.
Ichinohasama R; Miura I; Funato T; Sato I; Suzuki C; Saito Y; Decoteau JF; Myers JB; Kadin ME; Sawai T; Ooya K
Cancer Genet Cytogenet; 1998 Jul; 104(1):19-27. PubMed ID: 9648553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
